COPD symptoms vary depending on the amount of lung damage that has occurred due to inhaled substances, most commonly smoking. Symptoms are usually slow to develop and often don’t appear until there’s ...

Chronic obstructive pulmonary disease (COPD) is a lung condition that often hides in plain sight. You may think you’re dealing with a common cold, when in reality, your lungs are swollen, irritated ...

In 2021, an estimated 14 million adults in the United States reported a diagnosis of chronic obstructive pulmonary disease (COPD), chronic bronchitis, or emphysema. If you’re not sure what the ...

Director David Lynch is sharing his emphysema diagnosis with fans. (Photo by CHRIS DELMAS/AFP via Getty Images) “I’m homebound whether I like it or not,” he said. Lynch, who has not directed a feature ...

Chronic obstructive pulmonary disease (COPD) is a group of diseases that affect the lungs. The disease makes it difficult to breath and progressively gets worse. About 15 million Americans have been ...

Chronic obstructive pulmonary disease is frequently associated with cardiovascular, metabolic, and psychological diseases, all of which can negatively impact quality of life, exacerbations, and ...

Quitting won’t reverse damage from emphysema or stop it from progressing, but it can slow it down and greatly reduce your symptoms. If you quit smoking after finding out you have emphysema, you might ...

When you think about diseases that affect the lungs, like chronic obstructive pulmonary disease (COPD), there are likely some warning signs you already know, such as frequent wheezing and coughing.

Are you finding that your chronic obstructive pulmonary disease (COPD) is making it harder to do the things you enjoy? Canceling plans more often? Missing work due to flare-ups? It could mean your ...

Improving the health of the gut microbiome by way of fecal transplant (in mice) and dietary modification (in humans), has been shown by researchers to noticeably improve COPD symptoms. The finding ...

This add-on drug may help those with a type of lung inflammation that worsens symptoms like shortness of breath. The U.S. Food and Drug Administration has approved Dupixent (dupilumab) to reduce COPD ...